SM
Sean McCutcheon Raymond James Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
7
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $24 |
173%
upside
| 1 | -31% |
0
%
| 9 Jan ‘26 3 months ago |
|
|
|
Strong Buy
Maintained
| $76 |
44%
downside
| 2 | +53% |
0
%
| 17 Oct ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $12 |
16%
upside
| 1 | +64% |
0
%
| 11 Jul ‘25 9 months ago |
|
|
|
Outperform
Initiated
| $65 |
333%
upside
| 1 | -45% |
0
%
| 11 Jul ‘25 9 months ago |
|
|
|
Outperform
Reinstated
| $9 |
79%
upside
| 1 | +110% |
0
%
| 1 Jul ‘25 9 months ago |
|
|
|
Outperform
Reinstated
| $11 |
270%
upside
| 1 | -12% |
0
%
| 1 Jul ‘25 9 months ago |
|